Lilly to launch multi-dose weight-loss drug device in US
Eli Lilly wins FDA approval to launch a multi-dose KwikPen for its weight-loss drug Zepbound in the U.S.
Eli Lilly wins FDA approval to launch a multi-dose KwikPen for its weight-loss drug Zepbound in the U.S.